Aging retinal pigmented epithelium: Omics-based insights into vision decline
A new editorial paper titled "Aging retinal pigmented epithelium: omics-based insights into vision decline" has been ...
NewsX7h
New Eye Drops Show Promise in Slowing Vision Loss: Study
With promising results in animal models, researchers are now planning clinical trials to evaluate the safety and ...
Science Daily3d
New eye drops slow vision loss in animals
Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.
Managed Healthcare Executive4d
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells ...
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
B. Riley analyst Mayank Mamtani lowered the firm’s price target on Lineage Cell Therapeutics (LCTX) to $3 from $4 and keeps a Buy rating on the ...
U.S. researchers develop eye drops slowing vision loss in animals
Researchers at the U.S. National Institutes of Health (NIH) have developed eye drops that could slow vision loss in ...
Business Wire18d
Luxa Biotechnology Presents Clinical Data from First-in-Human Retinal Pigment Epithelium Cell Therapy Trial for Dry Age-Related Macular Degeneration at the 77th Annual Wills ...
FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age ...